Kisqali Femara Co-Pack 600 mg-2.5 mg Dose and Sofosbuvir and velpatasvir
Determining the interaction of Kisqali Femara Co-Pack 600 mg-2.5 mg Dose and Sofosbuvir and velpatasvir and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: letrozole / ribociclib
Brand name: Kisqali Femara Co-Pack 200 mg-25 mg Dose, Kisqali Femara Co-Pack 400 mg-25 mg Dose, Kisqali Femara Co-Pack 600 mg-25 mg Dose
Synonyms: Kisqali Femara Co-Pack 200 mg-2.5 mg Dose, Kisqali Femara Co-Pack
Generic Name: sofosbuvir / velpatasvir
Brand name: Epclusa
Synonyms: Sofosbuvir and Velpatasvir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Sofosbuvir Tablets
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Sofosbuvir, velpatasvir, and voxilaprevir
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Sojourn
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Sojourn Inhalant
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Solage
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Solage Topical
- Sofosbuvir and velpatasvir-Kitabis Pak
- Sofosbuvir and velpatasvir-Kitabis Pak inhalation
- Sofosbuvir and velpatasvir-Klofensaid II
- Sofosbuvir and velpatasvir-Klonopin
- Sofosbuvir and velpatasvir-Klonopin Wafer
- Sofosbuvir and velpatasvir-Klonopin Wafers